Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
EBS
EBS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest EBS ETF News Today | Earnings, Events & Price Alerts
EBS News
Flutter Entertainment Reports Disappointing Q4 Results, Shares Plunge
4d ago
Benzinga
U.S. Stocks Decline Midway; Dell Shares Surge Over 21%
4d ago
Benzinga
Emergent BioSolutions' 2026 Revenue Guidance Falls Short of Expectations
4d ago
seekingalpha
U.S. Stocks Drop Over 600 Points in Morning Trading
4d ago
Benzinga
Emergent BioSolutions Stock Drops 22% Following Decline in Q4 Revenue
4d ago
moomoo
Applied Optoelectronics Reports Strong Q4, Shares Surge
5d ago
Benzinga
Emergent BioSolutions Issues Weaker FY26 Revenue Guidance Below Consensus
5d ago
stocktwits
Emergent BioSolutions Q4 2025 Earnings Call Highlights
5d ago
seekingalpha
Emergent BioSolutions Authorizes New $50 Million Share Repurchase Program
5d ago
seekingalpha
Emergent Biosolutions Set to Announce Q4 Earnings on February 26
6d ago
seekingalpha
Emergent BioSolutions Receives FDA Approval for New NARCAN Multipack Configurations
Feb 13 2026
Benzinga
Emergent Receives FDA Approval for New NARCAN® Nasal Spray Multipacks
Feb 12 2026
Newsfilter
Emergent BioSolutions Receives FDA Approval for New NARCAN® Nasal Spray Multipacks
Feb 12 2026
Yahoo Finance
Emergent BioSolutions (EBS) Sued for Insider Trading, Agrees to $900K Settlement
Jan 16 2026
Benzinga
Emergent Biosolutions' Former CEO Sued for Insider Trading, Facing $900,000 Penalty
Jan 15 2026
stocktwits
Emergent BioSolutions (EBS) Receives FDA Approval for New NARCAN Nasal Spray Packaging
Jan 14 2026
NASDAQ.COM
Show More News
